Zydus Purchases 2 ANDAs from Teva


Zydus Healthcare has announced the purchase of 2 abbreviated new drug applications from Teva Pharmaceutical. The purchase was made in order to boost Zydus’ US portfolio.  Teva was required to divest the 2 ANDAs as a precondition to acquiring Allergan’s generic business.

Read the source article at The Economic Times

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>